A Dziatkowiak, Z Zdebski, W Tracz, W Piwowarska, M Garlicki, B Kapelak, T Tomaszczyk, M Migdal, T Wysocka, J Sadowski, R Pfitzner, J Nessler, E Pietrzyk, S Wojcik, P Rudzinski, A Lesniak
Ann Transplant 1996; 1(4): 65-66
Thepatient is a 28 year old woman who received a heart transplant in 1992 secondary to hypertrophic cardiomyopathy with unremarkable post-operative course. In the period immediately post transplantation the patient was on a four-drug immunosuppressive regimen which was subsequendy changed to standard three-agent therapy. This therapy was continued until the patient became pregnant. In the first trimester only Cyclosporine (CsA) was used, and thereafter, the patient was continued on the previous three agent regimen. Toward the end of pregnancy a rise in systolic pressure was observed, but the child was delivered by spontaneous vaginal delivery without complications in the 38th week of pregnancy. The newborn weighed 3320g and was in good health. A sharp fall in the newborn CsA blood levels was observed post delivery reaching zero level on the third day of life. At the present time, both mother and baby are in good health, 6 weeks after delivery.
Keywords: Heart Transplant, Pregnancy, Immunosuppression, newborn